Drug Profile
Panitumumab companion diagnostic - Illumina
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Illumina
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Colorectal-cancer(Diagnosis, Metastatic disease) in USA
- 15 Jan 2014 Clinical trials in Colorectal cancer (Diagnosis) in USA (unspecified route)